The US RNAi therapeutics market is expected to witness significant growth due to increasing investments in biotechnology research, rising adoption of advanced genetic therapies, and growing demand for targeted treatment solutions. The presence of leading pharmaceutical companies and strong research infrastructure is supporting the development and adoption of RNA-based therapeutic approaches...